Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9AR58
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.511 |
CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.582 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.496 |
CLV_PCSK_KEX2_1 | 104 | 106 | PF00082 | 0.544 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.550 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.574 |
CLV_PCSK_PC1ET2_1 | 38 | 40 | PF00082 | 0.550 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.734 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.517 |
DOC_USP7_UBL2_3 | 110 | 114 | PF12436 | 0.640 |
DOC_USP7_UBL2_3 | 25 | 29 | PF12436 | 0.687 |
DOC_USP7_UBL2_3 | 63 | 67 | PF12436 | 0.707 |
DOC_USP7_UBL2_3 | 90 | 94 | PF12436 | 0.525 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.614 |
LIG_14-3-3_CanoR_1 | 45 | 52 | PF00244 | 0.672 |
LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.696 |
LIG_BRCT_BRCA1_1 | 74 | 78 | PF00533 | 0.659 |
LIG_LIR_Gen_1 | 75 | 82 | PF02991 | 0.661 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.637 |
LIG_NRP_CendR_1 | 114 | 117 | PF00754 | 0.457 |
LIG_SUMO_SIM_anti_2 | 11 | 16 | PF11976 | 0.727 |
MOD_CDK_SPK_2 | 24 | 29 | PF00069 | 0.614 |
MOD_Cter_Amidation | 23 | 26 | PF01082 | 0.695 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.549 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.556 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.569 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.419 |
MOD_Plk_1 | 52 | 58 | PF00069 | 0.559 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.616 |
MOD_SUMO_for_1 | 59 | 62 | PF00179 | 0.664 |
TRG_DiLeu_BaEn_4 | 53 | 59 | PF01217 | 0.625 |
TRG_ER_diArg_1 | 103 | 106 | PF00400 | 0.561 |
TRG_NLS_Bipartite_1 | 25 | 42 | PF00514 | 0.661 |
TRG_NLS_MonoExtC_3 | 112 | 117 | PF00514 | 0.541 |
TRG_NLS_MonoExtC_3 | 36 | 41 | PF00514 | 0.657 |
TRG_NLS_MonoExtN_4 | 110 | 117 | PF00514 | 0.518 |
TRG_NLS_MonoExtN_4 | 35 | 42 | PF00514 | 0.578 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KMF1 | Bodo saltans | 48% | 82% |
A0A1X0NKS3 | Trypanosomatidae | 55% | 98% |
A0A3Q8IAX0 | Leishmania donovani | 94% | 100% |
A4H949 | Leishmania braziliensis | 83% | 100% |
A4HXG3 | Leishmania infantum | 94% | 100% |
C9ZNE7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 92% |
Q4QEA5 | Leishmania major | 94% | 100% |